According to Goldstein Research, medical cannabis market is expected to grow at a CAGR of 49.7% over the forecast period 2017-2025. Medical cannabis has gained legal status in various countries such as in Australia, Canada, Israel, the U.S, and Europe. The companies in the industry have varied target areas, such as some are focusing on nutraceuticals market due to the therapeutical benefits; whereas some other companies are manufacturing cannabis-based drugs to target multiple diseases such as epilepsy, cancer, and chronic pain. Furthermore, the expanding pharmaceuticals herbal extracts market at a CAGR of 8.2% during the forecast period, is also inducing the growth of the cannabis market. Cannabis is gaining attention from both biotechnology & pharmaceutical research & development segment of the healthcare industry &from the drug approval authorities. Browse Full Report: https://www.goldsteinresearch.com/report/medical-cannabis-market-marijuana-industry...